Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration (CORE Zambia)
Community-led Responses for Elimination (CoRE): A Cluster Randomized Controlled Trial of Reactive Case Detection Versus Reactive Drug Administration in Malaria Elimination Areas in Southern Province Zambia
Sponsor: AKROS Global Health
Listed as NCT02654912, this PHASE4 trial focuses on Malaria and remains completed. Sponsored by AKROS Global Health, it has been updated 10 times since 2016, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Mar 2021 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE4
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE4
▶ Show 5 earlier versions
-
Apr 2020 — Oct 2020 [monthly]
Recruiting PHASE4
-
Apr 2019 — Apr 2020 [monthly]
Recruiting PHASE4
-
Oct 2018 — Apr 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AKROS Global Health
- Ministry of Health, Zambia
- PATH
For direct contact, visit the study record on ClinicalTrials.gov .